Mobile technology used in Clinical Trial research to assess and
react to adverse events in real time

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jun 11, 2012 - assisTek, a clinical trial eSource solution provider,
today announced the use of their technology to collect
patient-reported Adverse Events. The software company,
headquartered in Scottsdale, AZ, has created a system where
patients can report adverse events on their
Android™-based eDiaries. The data is then automatically
transmitted, using cellular technology, to the study team. The
investigator is also alerted via email to enable a quick assessment
of any potential serious adverse events. The solution has been
hailed as a win-win by sponsors, patients, and investigators
alike.

Evonne Roberts, Director of Business Development, noted,
“The study team has the ability to review, update and
classify the adverse event using our online web Portal. This
provides them with the opportunity to determine severity and
potential treatment associations immediately. Technology has
granted study teams access to engage with patients in real time and
avoid complications and missed events due to waiting for site visit
appointments.” This feature is being used in Patient eDiaries
in Phase III studies around the world.

About assisTek: assisTek has successfully developed custom
eSource solutions used in clinical trials for over 18 years.
assisTek's solutions are delivered on Android™ tablets, and
include ePRO, eDiary, and Direct Clinical Data Capture.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.